{"id":"https://openalex.org/W7225830407","doi":"https://doi.org/10.3390/covid6110202","title":"Post-Pandemic Burden of Illness Among Patients in Germany Aged \u226560 Years with Acute or Persistent COVID-19","display_name":"Post-Pandemic Burden of Illness Among Patients in Germany Aged \u226560 Years with Acute or Persistent COVID-19","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225830407","doi":"https://doi.org/10.3390/covid6110202"},"language":"en","primary_location":{"id":"doi:10.3390/covid6110202","doi":"https://doi.org/10.3390/covid6110202","is_oa":true,"landing_page_url":"https://doi.org/10.3390/covid6110202","pdf_url":null,"source":{"id":"https://openalex.org/S4210226090","display_name":"COVID","issn_l":"2673-8112","issn":["2673-8112"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"COVID","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/covid6110202","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5139428898","display_name":"Mousumi Biswas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mousumi Biswas","raw_affiliation_strings":["Pfizer Inc., 66 Hudson Blvd East, New York, NY 10001, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., 66 Hudson Blvd East, New York, NY 10001, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055207305","display_name":"James Lucas","orcid":"https://orcid.org/0000-0002-9093-0134","observed_orcids":["https://orcid.org/0000-0002-9093-0134"]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Lucas","raw_affiliation_strings":["Adelphi Real World, Bollington SK10 5JB, UK"],"raw_orcid":"https://orcid.org/0000-0002-9093-0134","affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington SK10 5JB, UK","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034238873","display_name":"Tendai Mugwagwa","orcid":"https://orcid.org/0000-0001-7515-8548","observed_orcids":["https://orcid.org/0000-0001-7515-8548"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tendai Mugwagwa","raw_affiliation_strings":["Pfizer Ltd., Dorking Road, Tadworth, Surrey KT20 7NS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd., Dorking Road, Tadworth, Surrey KT20 7NS, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086919605","display_name":"Eveline Otte im Kampe","orcid":"https://orcid.org/0000-0002-9741-1193","observed_orcids":["https://orcid.org/0000-0002-9741-1193"]},"institutions":[{"id":"https://openalex.org/I4210100293","display_name":"Pfizer (Germany)","ror":"https://ror.org/00m8w3m39","country_code":"DE","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210100293"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Eveline Otte im Kampe","raw_affiliation_strings":["Pfizer Pharma GmbH, Friedrichstra\u00dfe 110, 10117 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Pharma GmbH, Friedrichstra\u00dfe 110, 10117 Berlin, Germany","institution_ids":["https://openalex.org/I4210100293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007212903","display_name":"Mohammad Ashraf Chaudhary","orcid":"https://orcid.org/0000-0001-6552-9093","observed_orcids":["https://orcid.org/0000-0001-6552-9093"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammad Ashraf Chaudhary","raw_affiliation_strings":["Pfizer Inc., 500 Arcola Rd, Collegeville, PA 19426, USA"],"raw_orcid":"https://orcid.org/0000-0001-6552-9093","affiliations":[{"raw_affiliation_string":"Pfizer Inc., 500 Arcola Rd, Collegeville, PA 19426, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122774941","display_name":"Abid A Kabir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Abid Kabir","raw_affiliation_strings":["Adelphi Real World, Bollington SK10 5JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington SK10 5JB, UK","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028931742","display_name":"Emily Qui\u00f1ones","orcid":"https://orcid.org/0000-0002-3473-151X","observed_orcids":["https://orcid.org/0000-0002-3473-151X"]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emily Quinones","raw_affiliation_strings":["Adelphi Real World, Bollington SK10 5JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington SK10 5JB, UK","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026054571","display_name":"James Piercy","orcid":"https://orcid.org/0000-0001-7015-1021","observed_orcids":["https://orcid.org/0000-0001-7015-1021"]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Piercy","raw_affiliation_strings":["Adelphi Real World, Bollington SK10 5JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington SK10 5JB, UK","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084480834","display_name":"Ruth Mokgokong","orcid":"https://orcid.org/0000-0002-6278-4969","observed_orcids":["https://orcid.org/0000-0002-6278-4969"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ruth Mokgokong","raw_affiliation_strings":["Pfizer Ltd., Dorking Road, Tadworth, Surrey KT20 7NS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd., Dorking Road, Tadworth, Surrey KT20 7NS, UK","institution_ids":["https://openalex.org/I189718659"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5139428898"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":1000,"currency":"CHF","value_usd":1207},"apc_paid":{"value":1000,"currency":"CHF","value_usd":1207},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"11","first_page":"202","last_page":"202"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11368","display_name":"Long-Term Effects of COVID-19","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11368","display_name":"Long-Term Effects of COVID-19","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.1907999962568283,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10168","display_name":"COVID-19 and Mental Health","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9368000030517578},{"id":"https://openalex.org/C2780966972","wikidata":"https://www.wikidata.org/wiki/Q86","display_name":"Headaches","level":2,"score":0.5302000045776367},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.5156000256538391},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.46970000863075256},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3393999934196472},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.3237000107765198},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.30000001192092896},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.2957000136375427},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.29269999265670776},{"id":"https://openalex.org/C2994026808","wikidata":"https://www.wikidata.org/wiki/Q557429","display_name":"Acute illness","level":2,"score":0.2924000024795532},{"id":"https://openalex.org/C3018822202","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Patient data","level":2,"score":0.28209999203681946},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.28049999475479126},{"id":"https://openalex.org/C2986834420","wikidata":"https://www.wikidata.org/wiki/Q5932254","display_name":"Age groups","level":2,"score":0.2800000011920929},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2741999924182892},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.26179999113082886},{"id":"https://openalex.org/C2781385661","wikidata":"https://www.wikidata.org/wiki/Q4677918","display_name":"Acute care","level":3,"score":0.25870001316070557},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.2581000030040741}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3390/covid6110202","doi":"https://doi.org/10.3390/covid6110202","is_oa":true,"landing_page_url":"https://doi.org/10.3390/covid6110202","pdf_url":null,"source":{"id":"https://openalex.org/S4210226090","display_name":"COVID","issn_l":"2673-8112","issn":["2673-8112"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"COVID","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3390/covid6110202","doi":"https://doi.org/10.3390/covid6110202","is_oa":true,"landing_page_url":"https://doi.org/10.3390/covid6110202","pdf_url":null,"source":{"id":"https://openalex.org/S4210226090","display_name":"COVID","issn_l":"2673-8112","issn":["2673-8112"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"COVID","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W2086325363","https://openalex.org/W2096382053","https://openalex.org/W2517885389","https://openalex.org/W2548191924","https://openalex.org/W2788008365","https://openalex.org/W4206950334","https://openalex.org/W4298395810","https://openalex.org/W4309027734","https://openalex.org/W4323971895","https://openalex.org/W4388461773","https://openalex.org/W4391219980","https://openalex.org/W4392155569","https://openalex.org/W4407034648","https://openalex.org/W4409557252","https://openalex.org/W4415518189","https://openalex.org/W7118179032","https://openalex.org/W7118195980","https://openalex.org/W7129494104","https://openalex.org/W7130614504"],"related_works":[],"abstract_inverted_index":{"Background/Objectives:":[0],"Post-pandemic,":[1],"real-world":[2],"evidence":[3],"on":[4],"COVID-19":[5,67,151,176,266],"in":[6,9,277,280],"elderly":[7,29],"patients":[8,30,51,89,112,148,202,261],"Germany":[10],"is":[11,284],"limited.":[12],"This":[13],"study":[14],"describes":[15],"the":[16,38,138,174,281],"clinical":[17],"characteristics,":[18],"treatment":[19,155],"patterns,":[20],"quality":[21],"of":[22,48,171,186,196,271],"life,":[23],"and":[24,50,107,119,191,216,233,256,275],"healthcare":[25],"resource":[26],"use":[27],"among":[28],"with":[31,55,149,203,262],"COVID-19.":[32],"Methods:":[33],"Data":[34],"were":[35,74,79,113,161,211,226,253],"derived":[36],"from":[37,68,173],"Adelphi":[39],"Real":[40],"World":[41],"COVID":[42],"Disease-Specific":[43],"Programme\u2122,":[44],"a":[45,184,194,268],"cross-sectional":[46],"survey":[47,179],"physicians":[49,84],"aged":[52],"\u226560":[53],"years":[54],"acute":[56,150,204,263],"(\u22644":[57],"weeks":[58],"post-diagnosis)":[59],"or":[60,205,264],"persistent":[61,95,206,265],"(symptom":[62],"duration":[63],"\u2265":[64],"12":[65],"weeks)":[66],"January":[69],"to":[70,178],"July":[71],"2024.":[72],"Analyses":[73],"descriptive;":[75],"comparisons":[76],"between":[77],"groups":[78],"not":[80],"performed.":[81],"Results:":[82],"151":[83],"provided":[85,212],"data":[86,210],"for":[87,201,248],"400":[88],"(acute":[90],"COVID-19,":[91,96,207],"n":[92,97],"=":[93,98,157,166,229,236],"200;":[94],"200).":[99],"The":[100,125,220],"mean":[101],"patient":[102],"age":[103],"was":[104,130,137,181,246],"68.1":[105],"(acute)":[106,215,255],"70.1":[108],"(persistent)":[109,218],"years.":[110],"Most":[111],"male":[114],"(acute,":[115,121,132],"56.0%;":[116],"persistent,":[117,123,134],"58.5%)":[118],"retired":[120],"68.0%;":[122],"78.5%).":[124],"most":[126,139,162,221],"common":[127,140,222],"concomitant":[128],"condition":[129],"hypertension":[131],"37.5%;":[133],"35.5%).":[135],"Tiredness/fatigue":[136],"physician-reported":[141],"symptom":[142],"(57.5%":[143],"acute;":[144],"67.5%":[145],"persistent).":[146,239],"For":[147],"that":[152],"received":[153],"prescribed":[154],"(n":[156,165,228,235],"62/200,":[158],"31.0%),":[159],"antivirals":[160],"commonly":[163],"used":[164],"59/62,":[167],"95.2%).":[168],"Mean":[169,240],"number":[170],"consultations":[172],"index":[175,242],"diagnosis":[177],"date":[180],"2.7":[182],"over":[183,193],"median":[185,195],"17.0":[187],"days":[188,198],"(Q1\u2013Q3:":[189,199],"7.0\u201344.0)":[190],"5.0":[192],"164.0":[197],"128.0\u2013225.0)":[200],"respectively.":[208],"Self-reported":[209],"by":[213],"98":[214],"107":[217],"patients.":[219],"patient-reported":[223],"worst":[224],"symptoms":[225],"headaches":[227],"15/98,":[230],"15.3%;":[231],"acute)":[232],"tiredness":[234],"14/107,":[237],"13.1%;":[238],"EQ-5D-5L":[241],"score":[243],"(German":[244],"weighting)":[245],"0.79":[247],"both":[249],"groups.":[250],"EQ-VAS":[251],"scores":[252],"66.1":[254],"66.0":[257],"(persistent).":[258],"Conclusions:":[259],"Elderly":[260],"have":[267],"notable":[269],"burden":[270],"illness.":[272],"Prioritizing":[273],"care":[274],"interventions":[276],"these":[278],"populations":[279],"post-pandemic":[282],"era":[283],"warranted.":[285]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}